Characteristic | CPA patients (n = 42) | Non-CPA patients (n = 60) |
---|---|---|
Male gender | 20 (47.6%) | 37 (61.7%) |
Age (years) (mean ± SD) | 54.6 ± 16.8 | 52.7 ± 18.1 |
Underlying lung diseases | ||
Bronchiectasis | 12 (28.6%) | 18 (30.0%) |
COPD | 8 (19.0%) | 10 (16.7%) |
Emphysema | 6 (14.3%) | 1 (1.7%) |
Previous tuberculosis | 3 (7.1%) | 4 (6.7%) |
Interstitial pneumonia | 2 (4.8%) | 2 (3.3%) |
Asthma | 2 (4.8%) | 8 (13.3%) |
Pulmonary embolism | 2 (4.8%) | 0 |
Prior pneumonia | 2 (4.8%) | 5 (8.3%) |
Chronic bronchitis | 2 (4.8%) | 8 (13.3%) |
Pulmonary sarcoidosis | 1 (2.4%) | 2 (3.3%) |
Eosinophilic pneumonia | 1 (2.4%) | 0 |
No underlying pulmonary diseases | 4 (9.5%) | 5 (8.3%) |
Underlying systemic diseases | ||
Diabetes mellitus | 6 (14.3%) | 9 (15.0%) |
Heart failure | 5 (11.9%) | 8 (13.3%) |
Rheumatic disease | 5 (11.9%) | 3 (5.0%) |
Chronic renal failure | 3 (7.1%) | 4 (6.7%) |
Chronic pulmonary or systemic symptoms | ||
Cough | 32 (76.2%) | 45 (75.0%) |
Sputum | 30 (71.4%) | 38 (63.3%) |
Fever | 19 (45.2%) | 34 (56.7%) |
Dyspnea | 17 (40.5%) | 30 (50.0%) |
Hemoptysis | 11 (26.2%) | 9 (15.0%) |
Chest pain | 2 (4.8%) | 2 (3.3%) |
Chest CT findings | ||
Bronchiectasis | 12 (28.6%) | 18 (30.0%) |
Consolidation | 8 (19.0%) | 9 (15.0%) |
Cavitation | 5 (11.9%) | 5 (8.3%) |
Pleural effusion | 4 (9.5%) | 8 (13.3%) |
Nodules | 4 (9.5%) | 19 (31.7%) |
Bullae of lung | 3 (7.1%) | 1 (1.7%) |
Fibrotic changes | 3 (7.1%) | 5 (8.3%) |
Pleural thickening | 3 (7.1%) | 3 (5.0%) |
Fungal ball | 2 (4.8%) | 0 |
Mass | 2 (4.8%) | 6 (10.0%) |
Halo sign | 2 (4.8%) | 0 |
Air crescent sign | 1 (2.4%) | 0 |